Evista

[Raloxifene]

Patient Info
Information for Patients

For safe and effective use of EVISTA, the physician should inform patients about the following: Patient Immobilization — EVISTA should be discontinued at least 72 hours prior to and during prolonged immobilization (e. g., post-surgical recovery, prolonged bed rest), and patients should be advised to avoid prolonged restrictions of movement during travel because of the increased risk of venous thromboembolic events. Hot Flashes or Flushes — EVISTA may increase the incidence of hot flashes and is not effective in reducing hot flashes or flushes associated with estrogen deficiency. In some asymptomatic patients, hot flashes may occur upon beginning EVISTA therapy.
Other Osteoporosis Treatment and Prevention Measures — Patients should be instructed to take supplemental calcium and/ or vitamin D, if daily dietary intake is inadequate. Weight-bearing exercise should be considered along with the modification of certain behavioral factors, such as cigarette smoking, and/ or alcohol consumption, if these factors exist.

Physicians should instruct their patients to read the patient package insert before starting therapy with EVISTA and to re-read it each time the prescription is renewed.